BackBanca Mediolanum S.p.A. Overview

Banca Mediolanum S.p.A. EBIT

Track Banca Mediolanum S.p.A.'s EBIT ($1.2B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$0.00

As of Sep 30, 2026

Annual EBIT (TTM)

$1.22B
↓ 19.79% YoY

Trailing 12 months ending Sep 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Banca Mediolanum S.p.A. (BMED.MI) FAQ

As of the most recent data (September 2026), BMED.MI shows a EBIT of $1.2B. That compares with $1.5B in the prior-year period — down 19.8% year over year. That is below the sector sector average of $2.4T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BMED.MI's EBIT is now $1.2B (was $1.5B) — a 19.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Banca Mediolanum S.p.A. is outperforming or lagging.

The its sector sector average EBIT is about $2.4T. Banca Mediolanum S.p.A. is at $1.2B, which is lower that average. That is roughly 99.9% below the sector mean. Use the comparison chart on this page to see how BMED.MI stacks up against individual peers as well.

Tracking BMED.MI's ebit over time shows whether Banca Mediolanum S.p.A. is scaling, shrinking, or reshaping that part of the business. The current reading is $1.2B That compares with $1.5B in the prior-year period — down 19.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Banca Mediolanum S.p.A.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $1.2B) with ownership activity and broader fundamentals.

Questions & Answers